[10] SURMOUNT-1 : Tirzepatide for the treatment of obesity produced ~2022% weight loss over 72 weeks, among the largest effects seen in pharmacologic obesity treatment
While the rats remained under anesthesia, strips of quadriceps muscle were collected and transferred to a Petri dish containing HBSS with 0.1% BSA
Side effects tend to go away the longer you are on tirzepatide but may flare up when you increase your dose
Image Credit: melitas / Shutterstock In a recent study published in the journal Nature Mental Health , researchers from the United Kingdom and Canada explored how glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for diabetes and obesity, might influence cognitive and mental health disorders
A fatty acid is attached to the lysine at position 20, increasing affinity for endogenous albumin, thereby extending its half-life and allowing for sustained therapeutic effects
But many people are not interested in taking a GLP-1 drug, cant tolerate them or cant afford them